2026 Q1 Business Overview Presentation via Meritz Securities NDR
-
Participating in Meritz Securities NDR to present 2026 Q1 business status and Q&A
-
Date: 2026-05-08 09:10, Location: Seoul, Audience: Domestic institutional investors, Format: 1:1 meetings
-
IR materials to be posted on company IR page (2026-04-30)
KOSPI Filing Information
-
Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
-
Company: Hanmi Pharm (128940)
-
Submission: Hanmi Pharm. Co., Ltd.
-
Receipt: 04-30-2026
-
Under KRX KOSPI Market Division